Your session is about to expire
← Back to Search
Behavioural Intervention
Yoga Therapy for Ovarian Cancer
N/A
Waitlist Available
Led By Lois Ramondetta, MD
Research Sponsored by M.D. Anderson Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Women with stage III-IV epithelial ovarian, fallopian tube, primary peritonal cancer with recommendations for NACT/IDS at recruitment
18 years of age or older
Must not have
Have completed chemotherapy
Extreme mobility issues (e.g., unable to get in and out of a chair unassisted)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group
Summary
This trial aims to offer a yoga therapy program to patients with certain types of cancer before they undergo chemotherapy and surgery. Researchers are studying how this program can improve the patients' quality of life and other health
Who is the study for?
This trial is for women with ovarian, fallopian tube, or primary peritoneal cancer who are about to start chemotherapy and have surgery planned. Details on specific inclusion and exclusion criteria are not provided.
What is being tested?
The study tests a Comprehensive Yoga Therapy (CYT) program designed as prehabilitation for nutritional, physical, and psychosocial support before patients undergo chemotherapy and surgery.
What are the potential side effects?
Yoga therapy is generally low-risk but may include muscle soreness or strain. The impact on individuals will vary based on their health condition.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have advanced ovarian, fallopian tube, or peritoneal cancer and am recommended for chemotherapy before surgery.
Select...
I am 18 years old or older.
Select...
I am scheduled for surgery at MD Anderson Cancer Center.
Select...
I can take care of myself and perform daily activities.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have finished my chemotherapy treatments.
Select...
I cannot get in and out of a chair without help.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: WLC - Wait List Control + ERASExperimental Treatment1 Intervention
Group II: CYT - Prehab Yoga Intervention + ERASExperimental Treatment1 Intervention
Find a Location
Who is running the clinical trial?
M.D. Anderson Cancer CenterLead Sponsor
3,070 Previous Clinical Trials
1,802,764 Total Patients Enrolled
46 Trials studying Ovarian Cancer
16,630 Patients Enrolled for Ovarian Cancer
Lois Ramondetta, MDPrincipal InvestigatorM.D. Anderson Cancer Center